➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Cryoprecipitate

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Cryoprecipitate?

Cryoprecipitate is an investigational drug.

There have been 25 clinical trials for Cryoprecipitate. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2020.

The most common disease conditions in clinical trials are Hemostatic Disorders, Blood Coagulation Disorders, and Hemorrhage. The leading clinical trial sponsors are CSL Behring, Emergency Medicine Foundation, and Australian Red Cross.

There are one hundred and one US patents protecting this investigational drug and nine hundred and ninety international patents.

Recent Clinical Trials for Cryoprecipitate
Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery PatientsOctapharmaPhase 4
Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery PatientsUniversity of VirginiaPhase 4
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard CareUniversity of Vermont Medical CenterPhase 3

See all Cryoprecipitate clinical trials

Clinical Trial Summary for Cryoprecipitate

Top disease conditions for Cryoprecipitate
Top clinical trial sponsors for Cryoprecipitate

See all Cryoprecipitate clinical trials

US Patents for Cryoprecipitate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cryoprecipitate   Start Trial Process for production of fibrinogen and fibrinogen produced thereby OCTAPHARMA AG (Lachen, CH)   Start Trial
Cryoprecipitate   Start Trial Hemostatic parameter display HemoSonics, LLC (Charlottesville, VA)   Start Trial
Cryoprecipitate   Start Trial Sterilization of blood and its derivatives with vitamins Biotest Pharma GmbH (Dreieich, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.